Literature DB >> 17163238

Healthcare use, social burden and costs of children with and without ADHD in Flanders, Belgium.

Annemieke De Ridder1, Diana De Graeve.   

Abstract

BACKGROUND: The purpose of this study was to provide quantitative information on the economic, social and emotional burden borne by families of children with attention-deficit hyperactivity disorder (ADHD) and on the public healthcare costs of a child with ADHD in Flanders, Belgium, and to compare costs of ADHD children with those of siblings without the disorder.
METHODS: A pilot-tested questionnaire was sent to all members of the Flemish ADHD society in February 2003. Parents were asked to record utilisation of healthcare, social care and other non-medical resources for their ADHD child and his/her sibling. In addition, data were collected on ADHD severity (IOWA-Conners Rating Scale) and on the sociodemographic and economic characteristics of the parents. Parents' out-of-pocket and public annual costs were calculated using tariffs. These costs were corrected for several confounding variables using general linear model (GLM) estimates.
RESULTS: ADHD affects school results and parents' productivity and places a psychological and emotional burden on the family. Childhood ADHD also results in a significantly higher use of healthcare: ADHD children have a significantly higher probability of visiting a general practitioner (60.3% vs 37.4%) and a specialist (50.9% vs 12.9%); they also visit the emergency department significantly more often (26% vs 12.1%), and they are hospitalised significantly more often (14% vs 8.4%). Consequently, Flemish children with ADHD incur significantly higher medical costs than their siblings without the disorder. Even after correction for several covariates, these cost differences are still striking. In fact, compared with their sibling, the annual cost for an ADHD child is more than six times higher for the parent (Euro 588.3 vs Euro 91.5), and public costs are twice as high (Euro 779 vs Euro 371.3) [year of costing 2002].
CONCLUSIONS: Childhood ADHD results in significantly higher use of healthcare and adversely affects academic achievements and parents' productivity.

Entities:  

Mesh:

Year:  2006        PMID: 17163238     DOI: 10.2165/00044011-200626020-00003

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


  21 in total

1.  Estimating log models: to transform or not to transform?

Authors:  W G Manning; J Mullahy
Journal:  J Health Econ       Date:  2001-07       Impact factor: 3.883

2.  Estimating marginal and incremental effects on health outcomes using flexible link and variance function models.

Authors:  Anirban Basu; Paul J Rathouz
Journal:  Biostatistics       Date:  2005-01       Impact factor: 5.899

3.  Generalized modeling approaches to risk adjustment of skewed outcomes data.

Authors:  Willard G Manning; Anirban Basu; John Mullahy
Journal:  J Health Econ       Date:  2005-05       Impact factor: 3.883

4.  Costs associated with attention deficit hyperactivity disorder: overview and future projections.

Authors:  James P Guevara; David S Mandell
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2003-04       Impact factor: 2.217

Review 5.  Multilevel models and health economics.

Authors:  N Rice; A Jones
Journal:  Health Econ       Date:  1997 Nov-Dec       Impact factor: 3.046

6.  Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder.

Authors:  C L Leibson; S K Katusic; W J Barbaresi; J Ransom; P C O'Brien
Journal:  JAMA       Date:  2001-01-03       Impact factor: 56.272

7.  Independent dimensions of hyperactivity and aggression: a validation with playroom observation data.

Authors:  R Milich; J Loney; S Landau
Journal:  J Abnorm Psychol       Date:  1982-06

8.  Parent, teacher, child. A trilateral approach to attention deficit disorder.

Authors:  M L Cohen; P C Kelly; A W Atkinson
Journal:  Am J Dis Child       Date:  1989-10

9.  Pharmacotherapies for attention-deficit/hyperactivity disorder: expected-cost analysis.

Authors:  A Marchetti; R Magar; H Lau; E L Murphy; P S Jensen; C K Conners; R Findling; E Wineburg; I Carotenuto; T R Einarson; M Iskedjian
Journal:  Clin Ther       Date:  2001-11       Impact factor: 3.393

10.  Children and adolescents with attention deficit-hyperactivity disorder: 1. Prevalence and cost of care.

Authors:  Larry Burd; Marilyn G Klug; Matthew J Coumbe; Jacob Kerbeshian
Journal:  J Child Neurol       Date:  2003-08       Impact factor: 1.987

View more
  18 in total

1.  Caregiver Preferences Regarding Personal Health Records in the Management of ADHD.

Authors:  Sarah D Ronis; Constance D Baldwin; Scott McIntosh; Kenneth McConnochie; Peter G Szilagyi; James Dolan
Journal:  Clin Pediatr (Phila)       Date:  2015-01-07       Impact factor: 1.168

2.  Global Economic Burden of Attention-Deficit/Hyperactivity Disorder: A Systematic Review.

Authors:  Anindit Chhibber; Alexandre Hikiji Watanabe; Chayutthaphong Chaisai; Sajesh K Veettil; Nathorn Chaiyakunapruk
Journal:  Pharmacoeconomics       Date:  2021-02-08       Impact factor: 4.981

Review 3.  Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature review.

Authors:  Eric Q Wu; Paul Hodgkins; Rym Ben-Hamadi; Juliana Setyawan; Jipan Xie; Vanja Sikirica; Ella X Du; Sherry Y Yan; M Haim Erder
Journal:  CNS Drugs       Date:  2012-07-01       Impact factor: 5.749

4.  Family Burden of Raising a Child with ADHD.

Authors:  Xin Zhao; Timothy F Page; Amy R Altszuler; William E Pelham; Heidi Kipp; Elizabeth M Gnagy; Stefany Coxe; Nicole K Schatz; Brittany M Merrill; Fiona L Macphee; William E Pelham
Journal:  J Abnorm Child Psychol       Date:  2019-08

5.  Altered functional brain connectivity in a non-clinical sample of young adults with attention-deficit/hyperactivity disorder.

Authors:  Luca Cocchi; Ivanei E Bramati; Andrew Zalesky; Emi Furukawa; Leonardo F Fontenelle; Jorge Moll; Gail Tripp; Paulo Mattos
Journal:  J Neurosci       Date:  2012-12-05       Impact factor: 6.167

6.  Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD).

Authors:  L Hakkaart-van Roijen; B W C Zwirs; C Bouwmans; S S Tan; T W J Schulpen; L Vlasveld; J K Buitelaar
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-05-04       Impact factor: 4.785

Review 7.  Pharmacological Treatment of Attention Deficit Hyperactivity Disorder During Pregnancy and Lactation.

Authors:  Asher Ornoy
Journal:  Pharm Res       Date:  2018-02-06       Impact factor: 4.200

8.  Cost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit hyperactivity disorder in children and adolescents.

Authors:  Vanja Sikirica; M Haim Erder; Jipan Xie; Dendy Macaulay; Melissa Diener; Paul Hodgkins; Eric Q Wu
Journal:  Pharmacoeconomics       Date:  2012-08-01       Impact factor: 4.981

9.  A systematic review of global publication trends regarding long-term outcomes of ADHD.

Authors:  Paul Hodgkins; L Eugene Arnold; Monica Shaw; Hervé Caci; Jennifer Kahle; Alisa G Woods; Susan Young
Journal:  Front Psychiatry       Date:  2012-01-18       Impact factor: 4.157

Review 10.  Annual research review: Child and adolescent mental health interventions: a review of progress in economic studies across different disorders.

Authors:  Jennifer Beecham
Journal:  J Child Psychol Psychiatry       Date:  2014-02-28       Impact factor: 8.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.